$ALNY
AI 분석생성일 May 11, 2026
AI Score
Hold$ALNY
Alnylam Pharmaceuticals
$ALNYNASDAQHealthcareLarge-Cap
Alnylam pioneers RNAi therapeutics for genetic diseases with Onpattro, Givlaari, and Oxlumo.
Market Cap
$32.0B
Revenue (TTM)
$2.5B
+45.0%
Net Income (TTM)
$0.1B
N/A
EPS (TTM)
$0.50
P/E Ratio
N/A
Dividend Yield
0.0%
52-Week Range
$150-$270
Beta
0.72
Dimension Scores
Fundamental
60Technical
64Sentiment
74Risk / Reward
58Momentum
78Financial Health
Profitability
65moderate
Growth
81strong
Liquidity
66strong
Solvency
62moderate
Efficiency
58moderate
Valuation, technical analysis, investment thesis, risk assessment and more for $ALNY
Free · No credit card required
면책 조항: AI 생성 분석은 교육 목적으로만 제공됩니다. 투자 조언이 아닙니다. 항상 자격을 갖춘 재무 상담사와 상담하세요.